HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AARP-Funded Researchers Say Forget About Supplements To Improve Memory

Executive Summary

Studies on supplements and brain health find no benefit in people with normal nutrient levels, says a group of 27 experts brought together by the American Association of Retired Persons. High-quality clinical studies of safety and efficacy of supplements in brain health outcomes are needed, they say.

You may also be interested in...



Wellness Market News: Prop 65 Proposal Changed, Goat Milk Formula Shows Gut Health Benefits

California changes Prop 65 reproductive-toxin averaging proposal; kratom group backs FDA enforcement on opioid treatment claims; oligosaccharides in goat milk formula show strong prebiotic, anti-pathogen adhesion properties; and CRN criticizes AARP-funded study on supplements and brain health as “inaccurate generalization.”

NPA Slams Study Linking Calcium, Vitamin D Use To Increased Cancer Risk

Annals of Medicine study finds at least 1,000mg/day calcium supplementation associated with increased risk of cancer, but no association of cancer and high levels of calcium from foods. Natural Products Association says study included an ‘unhealthy’ cohort of patients.

FDA Opens CBD Regulatory Path Docket, Warns Firms On Claims Missteps

With public hearing scheduled May 31 and a related public comment period, FDA "is interested in whether there are particular safety concerns that we should be aware of as we consider the FDA’s regulatory oversight and monitoring" of CBD products. Also influencing FDA's consideration is that CBD and other cannabis-derived substances are approved and being studied as drugs products, making their use as dietary ingredients noncompliant with agency regulations.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148909

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel